accuray.com (ARAY) Quick Liquidity

ARAY (Accuray Incorporated) - company brandmark

Accuray Incorporated (ARAY) faces threats from reductions in government healthcare spending and currency volatility, which is confirmed by the market dynamics reflected in the quotes on GURU.Markets, where the indicator stands at 0.73. The integration of software into hardware solutions creates a strong lock-in effect for medical centers to the brand. The company is currently focusing on implementing artificial intelligence into CyberKnife and Radixact systems to optimize therapy.

ARAY: Accuray Inc Intermediate Coverage Ratio 07/04/2022 - 10/29/2026
Finished products of Accuray

The stability of Accuray Incorporated relies on long-term commitments from component suppliers for robotic radiation therapy systems. The mathematical basis of the metric excludes inventory, focusing instead on the most liquid assets. The ratio determines the business's ability to instantaneously settle short-term debts using cash and accounts receivable. The price action of the critical assessment ratio allows investors to differentiate temporary cash flow gaps from a systemic financial crisis.

Analysis of competing companies

ONC: Quick Ratio|Immediate Liquidity Halozyme Corp (HALO)|Quick Liquidity Revolution Medicines|AAPG: Intermediate Coverage Ratio|Quick Liquidity Indicator CGON (CG Oncology)|URGN (UroGen Pharma Ltd) - Intermediate Coverage Ratio|Quick Ratio BCAX (Bicara Bio)|PSNL - Quick Liquidity Indicator|ERAS: Quick Liquidity Indicator|DCTH - Quick Ratio|Y-mAbs Therapeutics, Inc. (YMAB) - Quick Liquidity|Aura Biosciences Inc - Intermediate Coverage Ratio|CADL (Candel Therapeutics Inc.) - Quick Ratio|Immediate Liquidity SELLAS Life Sciences Group Inc. SLS|Quick Ratio ACTU|Quick Ratio citiusonc.com (CTOR)|Quick Ratio HURA (TuHURA Biosciences)|TARA - Quick Liquidity Indicator|Fate Therapeutics Corp - Quick Ratio|Aadi Bioscience Inc (WHWK) - Quick Liquidity Indicator|TCRX (tscan.com) - Quick Liquidity Indicator|Champions Oncology, Inc. (CSBR) - Quick Ratio|Quick Liquidity XBiotech Inc|CVM: Intermediate Coverage Ratio|Quick Ratio OSTX|Quick Ratio radiopharmtheranostics.com (RADX)|Artiva Biotherapeutics - Quick Liquidity Indicator|Adlai Nortye Ltd (ANL) - Immediate Liquidity|VERU: Quick Liquidity Indicator|Intermediate Coverage Ratio TPST (Tempest Therapeutics Inc)|XLO: Quick Ratio|RENB - Interim Coverage Ratio|Quick Liquidity Mural Oncology PLC|Immediate Liquidity Ratio KAPA (Kairos Pharma Inc)|Quick Ratio OKUR|Quick Liquidity Indicator w2.cytomed.sg GDTC|Quick Liquidity Curis CRIS|Apollomics Inc. (APLM) - Immediate Liquidity|THAR - Quick Liquidity|Intermediate Coverage Ratio ADVB (Advanced Biomed Inc)|Genprex (GNPX) - Quick Liquidity|Critical Liquidity Ratio CLDI (Calidi Biotherapeutics, Inc.)|Quick Liquidity Sunshine Biopharma, Inc.|Immediate Liquidity Xenetic Bio XBIO|Quick Liquidity Salarius Pharmaceuticals (SLRX)|PPBT (purple-biotech.com) - Intermediate Coverage Ratio|Quick Ratio AONC (American Oncology Network, Inc.)|Quick Ratio BeiGene Ltd. BGNE|CKPT: Quick Liquidity Indicator|elevationoncology.com - Intermediate Liquidity Ratio|ICAD: Quick Ratio|Immediate Liquidity Ikena Oncology (IKNA)|NTBL (Notable Labs) - Quick Ratio|Immediate Liquidity Ratio VIRX (Viracta)|Quick Ratio MOR|Quick Ratio NAYA Biosciences Corp (NAYA)|Quick Liquidity Ascentage Pharma Group AAPGV